- Weight-Loss Drug Zepbound May Lower Heart Failure Deaths
- Nearly 160 Million Americans Harmed by Another’s Drinking, Drug Use
- 1 in 4 Americans Now Struggling to Cover Medical Costs
- Getting Fitter Can Really Help Keep Dementia at Bay
- Skin Patch Could Monitor Your Blood Pressure
- There May Be a Better Way to Treat Hematoma Brain Bleeds
- Chronic Joint Pain Plus Depression Can Take Toll on the Brain
- Living in Space Won’t Permanently Harm Astronauts’ Thinking Skills
- Kids’ Injuries in Sports and at Home: When Is It Right to Seek Medical Attention?
- Human Cell Atlas Will Be ‘Google Maps’ for Health Research
Combination Antibiotic Zerbaxa Approved
The combination antibiotic Zerbaxa (ceftolozane/tazobactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated abdominal infections and complicated urinary tract infections.
The approval for abdominal infections was approved in combination with another drug, metronidazole, the agency said in news release. The approval for urinary tract infection includes infection of the kidney.
Zerbaxa is the fourth antibiotic to be FDA-approved in 2014, following approval of Dalvance (dalbavancin), Sivextro (tedizolid) and Orbactiv (oritavancin).
The drug’s label includes a warning about decreased effectiveness among people with kidney impairment, the FDA said. The most common side effects reported during clinical testing included nausea, diarrhea, headache and fever.
Zerbaxa is marketed by Cubist Pharmaceuticals, based in Lexington, Mass.
More information
To learn more, visit the FDA.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.
Related
-
-120x134.jpg)
More Hot Flashes Could Mean Higher Odds for Type 2 DiabetesMenopausal women with frequent hot flashes and night sweats...
- November 4, 2024
-
Late-Life Menopause Linked to Higher Asthma RiskWomen who enter menopause at a later age have...
- October 30, 2024
-
Biden Proposes That Insurers Cover Over-the-Counter Birth ControlHealth insurers would be required to cover the cost...
- October 21, 2024
-
Some IUDs May Raise The Odds for Breast Cancer, But Overall Risk Remains LowIntrauterine devices (IUDs) may raise the chances of a...
- October 18, 2024
-200x224.jpg)
